<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75141</identifier>
<setSpec>0034-0618</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">(Cu)II in vivo interaction with cefotaxime</dc:title>
<dc:description xml:lang="en">The presence of Cu(II) in penicillin and cephalosporin solutions,has been proved, to promote in vitro the antibiotic degradation tothe corresponding acid derivates. HPLC studies provided anadditional evidence for the reaction mechanism. The mechanisms ofCu(II) catalysis involve a ternary complex. This work was undertakento study the consequences of this degradation in vivo upper thepharmacokinetic, pharmacodynamic and activity of the antibioticcefotaxime. It is one of the most used «third-generation»cephalosporin in the world, this is because of that the interactioncefotaxime-metal deserved our attention. Our results remarked alower concentration of free cefotaxime in blood, liver, spleen, kidney,lung and heart in organs from animals suffering Cu-intoxication.The differences more significant between intoxicated and controlrats were observed in liver, lung and kidney. In addition cefotaximelinked to copper lose most of the microbicidal activity againstbacterial strains of Bacillus subtilis CECT 356, Escherichia coli CECT434, Escherichia coli CECT 616, Staphilococus aureus spp aureusCECT 435, Staphilococus aureus spp aureus CECT 239, in plate tests.It means that cefotaxime would become ineffective as antibiotic inmetal poisoned patients(AU)</dc:description>
<dc:creator>Casas, Juan de Dios</dc:creator>
<dc:creator>Madrigal, Pilar</dc:creator>
<dc:creator>Doadrio, Antonio L</dc:creator>
<dc:language>en</dc:language>
<dc:description xml:lang="es">Este trabajo estudia la reacción del cobre II con una cefalosporina,la cefotoxima, in vivo; los mecanismos catalíticos que implicanla presencia de complejos ternarios, su farmacocinética y su farmacodinamiaque afectan a la actividad del antibiótico. Las diferenciasmás significativas entre las ratas intoxicadas y control fueron observadasen riñón, pulmón e hígado. También hemos estudiado la actividadmicrobicida en Bacillus subtilis CECT 356, Escherichia coliCECT 434, Escherichia coli CECT 616, Staphilococus aureus sppaureus CECT 435, Staphilococus aureus spp aureus CECT 239(AU)</dc:description>
<dc:source>An Real Acad Farm;75(2): 217-231, abr.-jun. 2009. ilus, tab</dc:source>
<dc:identifier>ibc-75141</dc:identifier>
<dc:title xml:lang="es">Interacción in vivo del Cu(II) con cefotaxima</dc:title>
<dc:subject>^d3321^s22068</dc:subject>
<dc:subject>^d3321^s29165</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d12345</dc:subject>
<dc:subject>^d10600</dc:subject>
<dc:subject>^d911</dc:subject>
<dc:subject>^d2547</dc:subject>
<dc:subject>^d2900^s22045</dc:subject>
<dc:subject>^d2475^s22078</dc:subject>
<dc:subject>^d4409</dc:subject>
<dc:subject>^d2475^s22079</dc:subject>
<dc:type>article</dc:type>
<dc:date>200906</dc:date>
</metadata>
</record>
</ibecs-document>
